Organogenesis Holdings Inc (ORGO) stock is down -65.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ORGO stock a score of 33 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 1. ORGO's rank also includes a long-term technical score of 33. The fundamental score for ORGO is 64. In addition to the average rating from Wall Street analysts, ORGO stock has a mean target price of $17.00. This means analysts expect the stock to climb 185.23% over the next 12 months. ORGO has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ORGO!